Chat with us, powered by LiveChat

Author name: emma.scrafton

Hi, I'm Emma, and I work within the Marketing team at Lhasa Limited. I have a masters degree in Chemistry.

Sarah Nexus frequently asked questions

Everything you need to know about Sarah Nexus

The use of in silico prediction systems has become an essential part of regulatory submissions when assessing the genotoxic potential of chemicals. Guidelines such as those from the EMA, US FDA, and ICH highlight their importance. Most notably, the ICH M7 guidance explicitly requires the application of two complementary quantitative/qualitative structure-activity relationship ((Q)SAR) systems to […]

Everything you need to know about Sarah Nexus Read More »

EUROTOX 2024: A memorable gathering in Copenhagen

EUROTOX 2024: Advancing toxicology in Copenhagen

We had a fantastic time at EUROTOX 2024, held from 8 – 11th September in the picturesque city of Copenhagen, Denmark. This year’s theme, “Toxicology – A Quest for Safe Chemicals and Medicines”, was reflected in the diverse sessions, posters and presentations throughout the event. Key topics ranged from the safety of drugs and environmental

EUROTOX 2024: Advancing toxicology in Copenhagen Read More »

Blog image 2

A step towards animal-free developmental and reproductive toxicity safety assessments

Developmental and reproductive toxicity (DART) is a critical area of toxicology that is required to assess the impact of new chemicals on adult fertility and embryo development. Industries across the globe rely on DART assessments to safeguard human health, adhering to regulatory standards like those outlined in the ICH S5 (R3) guideline. However, the current

A step towards animal-free developmental and reproductive toxicity safety assessments Read More »

Blog image 1

10 frequently asked questions about Derek Nexus, answered

For over four decades, at Lhasa Limited we have been developing scientific software solutions that enable scientists to make informed decisions on the safety of drugs, chemicals and cosmetics. Our journey advanced significantly with the creation of Derek Nexus, an in silico expert knowledge-based toxicity prediction tool. As regulatory landscapes evolved and the push for

10 frequently asked questions about Derek Nexus, answered Read More »

Supporting the safe use of CDB in skincare products using Derek Nexus

Supporting the safe use of CBD in skincare products using Derek Nexus

Cannabidiol (CBD) is gaining prominence as a sought-after ingredient in skincare and beauty formulations, thanks to its notable anti-inflammatory, antioxidant and anti-bacterial properties. Derived directly from the hemp plant, this compound is increasingly being used as an ingredient in skincare products, particularly for the management of various skin conditions like eczema, dermatitis and psoriasis. Despite

Supporting the safe use of CBD in skincare products using Derek Nexus Read More »

Scientist Spotlight: Poster Shortlisted for Top 10 Best Risk Assessment Abstract at Society of Toxicology!

Scientist Spotlight: Poster Shortlisted for Top 10 Best Risk Assessment Abstract at Society of Toxicology!

One of our three Lhasa Limited posters during the recent Society of Toxicology 63rd annual meeting was selected for the top 10 best risk assessment abstract award by the Risk Assessment Speciality Section! Authored by Lhasa scientist, Pooja Tomar, the poster titled “Best practice for conducting expert review of sensitisation data and predictions​” highlights the critical

Scientist Spotlight: Poster Shortlisted for Top 10 Best Risk Assessment Abstract at Society of Toxicology! Read More »

Lhasa Limited publication awards 2023

The ultimate 2024 reading list, as chosen by our members!

Throughout 2023, our dedicated team contributed significantly to various journals through authoring and co-authoring a plethora of publications. Here are the articles, as voted by our members, which stood out above the rest. Organised into 5 compelling categories; Extractables and Leachables, Nitrosamines, Potentially Mutagenic Impurities (PMIs), Data Sharing and Safety Profiling in Drug Discovery, we

The ultimate 2024 reading list, as chosen by our members! Read More »

Copy of Blog images 1080 × 864 px 2

Q&A deep dive with Martin Walter: How to establish AI limits for NDSRIs

Building on the success of our recent webinar, How to establish acceptable intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs), we’re thrilled to present a follow-up that brings you closer to the insightful discussions that unfolded during the interactive Q&A session. In this blog, we’ve gathered questions posed during the webinar and curated written

Q&A deep dive with Martin Walter: How to establish AI limits for NDSRIs Read More »